Chromosome 4, trisomy 4q21
Chromosome 4, trisomy 4q21 is a rare genetic disorder characterized by the presence of an extra copy of genetic material on the long arm (q arm) of chromosome 4, specifically in the region designated as 4q21. This condition is a type of chromosomal abnormality known as a partial trisomy, where only a segment of the chromosome is present in three copies rather than the entire chromosome. The clinical manifestations and severity of symptoms associated with trisomy 4q21 can vary widely among affected individuals.
Symptoms and Diagnosis[edit]
The symptoms of trisomy 4q21 can vary significantly but often include developmental delay, intellectual disability, and physical abnormalities. Common physical features may include distinct facial characteristics, skeletal anomalies, heart defects, and other organ abnormalities. Due to the variability in symptoms, the diagnosis of trisomy 4q21 is typically confirmed through genetic testing, such as karyotyping or more advanced genomic techniques like fluorescence in situ hybridization (FISH) or array comparative genomic hybridization (aCGH).
Causes[edit]
Trisomy 4q21 results from a duplication of a portion of the q arm of chromosome 4. This duplication can occur randomly during the formation of reproductive cells or early in fetal development. In some cases, it may also result from a balanced translocation in one of the parents, where no genetic material is lost or gained in the parent but can lead to an unbalanced distribution in the offspring.
Treatment and Management[edit]
There is no cure for trisomy 4q21, and treatment is symptomatic and supportive. Management may involve a multidisciplinary team including pediatricians, geneticists, surgeons, cardiologists, neurologists, and therapists (physical, occupational, and speech) to address the various symptoms and complications that can arise. Early intervention and supportive therapies can help improve the quality of life and developmental outcomes for individuals with this condition.
Prognosis[edit]
The prognosis for individuals with trisomy 4q21 varies depending on the severity of symptoms and associated complications. Some individuals may have mild symptoms and lead relatively normal lives, while others may experience significant physical and intellectual disabilities. Early diagnosis and intervention can play a crucial role in managing the condition and improving the overall prognosis.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
